Page last updated: 2024-10-21

vanilmandelic acid and Ehlers-Danlos Syndrome

vanilmandelic acid has been researched along with Ehlers-Danlos Syndrome in 1 studies

Vanilmandelic Acid: A 3-O-methyl ether of 3,4-dihydroxymandelic acid. It is an end-stage metabolite of CATECHOLAMINES; EPINEPHRINE; and NOREPINEPHRINE.
vanillylmandelic acid : An aromatic ether that is the 3-O-methyl ether of 3,4-dihydroxymandelic acid.

Ehlers-Danlos Syndrome: A heterogeneous group of autosomally inherited COLLAGEN DISEASES caused by defects in the synthesis or structure of FIBRILLAR COLLAGEN. There are numerous subtypes: classical, hypermobility, vascular, and others. Common clinical features include hyperextensible skin and joints, skin fragility and reduced wound healing capability.

Research Excerpts

ExcerptRelevanceReference
"Disulfiram was orally given, in addition to a parenteral administration of copper-histidine in the case of MD patients."2.77Effects of disulfiram treatment in patients with Menkes disease and occipital horn syndrome. ( Kodama, H; Ogawa, E, 2012)

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's1 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Ogawa, E1
Kodama, H1

Trials

1 trial available for vanilmandelic acid and Ehlers-Danlos Syndrome

ArticleYear
Effects of disulfiram treatment in patients with Menkes disease and occipital horn syndrome.
    Journal of trace elements in medicine and biology : organ of the Society for Minerals and Trace Elements (GMS), 2012, Volume: 26, Issue:2-3

    Topics: Adolescent; Adult; Ceruloplasmin; Copper; Cutis Laxa; Disulfiram; Dopamine; Ehlers-Danlos Syndrome;

2012